News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

June

17

Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration

Goal to Develop a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia...

11

Exagen Inc. Reports First Quarter 2020 Results

AVISE® Testing Volumes Increase with Retention Rate of 99% SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE)...

25

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

AVISE® Testing Revenue Drives 24% Revenue Growth SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

24

Exagen Appoints Chief Medical and Chief Scientific Officers

The additions of Debra Jeske Zack, M.D., Ph.D., as CMO, and Anja Kammesheidt, Ph.D.,...